首页 > 最新文献

Clinical Toxicology最新文献

英文 中文
Analysis of clinical challenges and prognostic risk factors for 195 cases of iatrogenic botulism in China. 195例医源性肉毒杆菌中毒的临床挑战及预后危险因素分析
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-04-28 DOI: 10.1080/15563650.2025.2491662
Yaqing An, Baopu Lv, Tuokang Zheng, Yu Gong, Jianhang Hou, Heyule Tian, Fangyu Chen, Bokai Wei, Jiajia Lu, Yiming Yun, Penglong Yang, Muchao Zhang, Zeqing Hu, Yang Wu, Hengbo Gao, Yingping Tian, Dongqi Yao

Introduction: Improper use of botulinum neurotoxin may result in poisoning. This study aimed to investigate the causes, characteristics, and risk factors of iatrogenic botulism incidents in China.

Methods: Patients diagnosed with iatrogenic botulism who presented to the emergency department of the Second Hospital of Hebei Medical University between June and July 2024 were included. We assessed baseline demographics, clinical symptoms, disease grade, and botulinum toxin type A-related variables. Multivariate regression analysis was used to identify independent risk factors influencing the 30-day prognosis.

Results: A total of 195 patients were included in the study, with a median age of 38 years (IQR: 33-47 years) and a male-to-female ratio of 1:38. Blurred vision was the most common early feature (82.1%), followed by dizziness and ptosis (75.9%), fatigue (65.1%), and dysarthria (63.1%). The most frequently observed complications were acute gastroenteritis (9.7%), followed by aspiration pneumonia (7.2%). Fifty-one patients experienced severe poisoning with early ocular, facial, limb muscle, and respiratory muscle involvement. Thirty-two patients (16.4%) required mechanical ventilation. The median latent period was 3 days (IQR: 2-4 days), with a median interval of 7 h (IQR: 4-10 h) observed between symptom onset and antitoxin administration. The median duration of hospitalization was 6 days (IQR: 4-8 days). Adverse reactions to the antitoxin included serum sickness in 11 patients and allergic reactions in 20 patients. Based on the presence or absence of clinical signs 30 days post-discharge, we categorized the cohort into good and poor prognostic groups; 87 patients (44.6%) had a poor prognosis. Independent risk factors for a poor prognosis included a latent period ≤3 days, increased time from onset of features to antitoxin treatment, longer hospital duration, disease severity, and need for mechanical ventilation.

Discussion: Iatrogenic botulism frequently leads to severe outcomes due to delayed diagnosis and intervention. We identified a disease severity grading system alongside additional risk factors to predict patient prognosis.

Conclusion: Our study underscores the critical importance of early recognition and timely treatment of iatrogenic botulism. Clinicians should implement prompt treatment to mitigate disease progression.

简介:肉毒杆菌神经毒素使用不当可能导致中毒。本研究旨在探讨中国医源性肉毒中毒事件的原因、特点及危险因素。方法:选取2024年6 - 7月河北医科大学第二医院急诊科诊断为医源性肉毒杆菌中毒的患者。我们评估了基线人口统计学、临床症状、疾病等级和a型肉毒杆菌毒素相关变量。采用多因素回归分析确定影响30天预后的独立危险因素。结果:共纳入195例患者,中位年龄38岁(IQR: 33-47岁),男女比例为1:38。视力模糊是最常见的早期特征(82.1%),其次是头晕和上睑下垂(75.9%),疲劳(65.1%)和构音障碍(63.1%)。最常见的并发症是急性胃肠炎(9.7%),其次是吸入性肺炎(7.2%)。51例患者出现严重中毒,早期眼部、面部、肢体肌肉和呼吸肌受累。32例(16.4%)患者需要机械通气。中位潜伏期为3天(IQR: 2-4天),从症状出现到抗毒素给药的中位间隔为7小时(IQR: 4-10小时)。中位住院时间为6天(IQR: 4-8天)。抗毒素不良反应包括血清病11例,过敏反应20例。根据出院后30天是否存在临床体征,我们将队列分为预后良好组和预后不良组;预后不良87例(44.6%)。预后不良的独立危险因素包括潜伏期≤3天、从发病到抗毒素治疗时间增加、住院时间延长、病情严重程度和需要机械通气。讨论:医源性肉毒杆菌中毒往往导致严重的后果,由于延误诊断和干预。我们确定了一种疾病严重程度分级系统以及其他危险因素来预测患者预后。结论:我们的研究强调了医源性肉毒杆菌中毒的早期识别和及时治疗的重要性。临床医生应及时实施治疗以减缓疾病进展。
{"title":"Analysis of clinical challenges and prognostic risk factors for 195 cases of iatrogenic botulism in China.","authors":"Yaqing An, Baopu Lv, Tuokang Zheng, Yu Gong, Jianhang Hou, Heyule Tian, Fangyu Chen, Bokai Wei, Jiajia Lu, Yiming Yun, Penglong Yang, Muchao Zhang, Zeqing Hu, Yang Wu, Hengbo Gao, Yingping Tian, Dongqi Yao","doi":"10.1080/15563650.2025.2491662","DOIUrl":"10.1080/15563650.2025.2491662","url":null,"abstract":"<p><strong>Introduction: </strong>Improper use of botulinum neurotoxin may result in poisoning. This study aimed to investigate the causes, characteristics, and risk factors of iatrogenic botulism incidents in China.</p><p><strong>Methods: </strong>Patients diagnosed with iatrogenic botulism who presented to the emergency department of the Second Hospital of Hebei Medical University between June and July 2024 were included. We assessed baseline demographics, clinical symptoms, disease grade, and botulinum toxin type A-related variables. Multivariate regression analysis was used to identify independent risk factors influencing the 30-day prognosis.</p><p><strong>Results: </strong>A total of 195 patients were included in the study, with a median age of 38 years (IQR: 33-47 years) and a male-to-female ratio of 1:38. Blurred vision was the most common early feature (82.1%), followed by dizziness and ptosis (75.9%), fatigue (65.1%), and dysarthria (63.1%). The most frequently observed complications were acute gastroenteritis (9.7%), followed by aspiration pneumonia (7.2%). Fifty-one patients experienced severe poisoning with early ocular, facial, limb muscle, and respiratory muscle involvement. Thirty-two patients (16.4%) required mechanical ventilation. The median latent period was 3 days (IQR: 2-4 days), with a median interval of 7 h (IQR: 4-10 h) observed between symptom onset and antitoxin administration. The median duration of hospitalization was 6 days (IQR: 4-8 days). Adverse reactions to the antitoxin included serum sickness in 11 patients and allergic reactions in 20 patients. Based on the presence or absence of clinical signs 30 days post-discharge, we categorized the cohort into good and poor prognostic groups; 87 patients (44.6%) had a poor prognosis. Independent risk factors for a poor prognosis included a latent period ≤3 days, increased time from onset of features to antitoxin treatment, longer hospital duration, disease severity, and need for mechanical ventilation.</p><p><strong>Discussion: </strong>Iatrogenic botulism frequently leads to severe outcomes due to delayed diagnosis and intervention. We identified a disease severity grading system alongside additional risk factors to predict patient prognosis.</p><p><strong>Conclusion: </strong>Our study underscores the critical importance of early recognition and timely treatment of iatrogenic botulism. Clinicians should implement prompt treatment to mitigate disease progression.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"337-342"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143964505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure in the United States and Canada: a consensus guideline. 美国和加拿大对乙酰氨基酚(对乙酰氨基酚)暴露的院外评估和分流:共识指南。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-06 DOI: 10.1080/15563650.2025.2471915
Evelyn J Fox, Alicia M Dalton, Michael E Mullins, Theresa Matoushek, Anne-Michelle Ruha, Michele M Burns, Karen Simone, Michael C Beuhler, Kennon J Heard, Maryann Mazer-Amirshahi, Christine M Stork, Shawn M Varney, Alexandra R Funk, F Lee Cantrell, Jon B Cole, William Banner, Andrew I Stolbach, Robert G Hendrickson, Scott N Lucyk, Marco L A Sivilotti, Mark K Su, Lewis S Nelson, Barry H Rumack, Richard C Dart

Introduction: Consensus guidelines for out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure were published in 2006. Changes in the healthcare system, paracetamol ingestion trends, and availability of paracetamol-containing products necessitate an update to these guidelines. Updated guidelines were created for out-of-hospital management of paracetamol exposure in the United States and Canada.

Methods: A modified Delphi consensus methodology was used to create a decision framework to evaluate clinical aspects of care related to paracetamol overdose in the out-of-hospital setting. Twenty-one panelists were selected by four clinical toxicology societies (America's Poison Centers®, American Academy of Clinical Toxicology, American College of Medical Toxicology, and Canadian Association for Poison Centres and Clinical Toxicology) to participate as panelists. Guidelines were collected from most poison centers in the United States and Canada, and systematic collection and review of medical literature was conducted.

Results: The panel developed a guideline for out-of-hospital management of paracetamol exposure that encompasses acute and repeated supratherapeutic ingestion patterns. Acute ingestion is defined as any ingestion presenting within 24 h of initial ingestion, regardless of ingestion pattern. Repeated supratherapeutic ingestion is defined as an exposure that occurs over a period of 24 h or more. This guideline emphasizes the importance of obtaining accurate history. When ingestion history is determined as accurate, dosage and ingestion pattern are used to decide treatment referral. It is recommended that patients be referred to the emergency department if their ingestion amount is: (1) ≥200 mg/kg or 10 g (whichever is less) within 24 h; (2) ≥150 mg/kg/24 h or 6 g/day (whichever is less) within 48 h; (3) ≥100 mg/kg/24 h or 4 g/day (whichever is less) for more than 48 h.

Discussion: The need for standardizing the out-of-hospital assessment and triage of paracetamol exposure is pressing. Despite the availability of acetylcysteine, some patients develop fatal liver failure due to missed diagnoses and delays in treatment. Failure to recognize cases requiring acetylcysteine is associated with significant morbidity and mortality.

Conclusion: This consensus statement provides evidence-based guidance for out-of-hospital management of paracetamol ingestion to standardize healthcare facility referral criteria for paracetamol exposed patients.

2006年发表了院外评估和对乙酰氨基酚(扑热息痛)暴露分诊的共识指南。医疗保健系统的变化、扑热息痛摄入趋势以及含扑热息痛产品的可获得性需要更新这些指南。美国和加拿大为院外扑热息痛暴露管理制定了最新指南。方法:采用改进的德尔菲共识方法创建决策框架,以评估院外环境中与扑热息痛过量相关的临床护理方面。四个临床毒理学学会(美国毒物中心®、美国临床毒理学学会、美国医学毒理学学院和加拿大毒物中心和临床毒理学协会)选出了21名专家小组成员作为小组成员参加会议。收集了美国和加拿大大多数中毒中心的指南,并对医学文献进行了系统的收集和回顾。结果:专家组制定了院外扑热息痛暴露管理指南,包括急性和重复超治疗摄入模式。急性摄食被定义为在初始摄食后24小时内出现的任何摄食,无论摄食方式如何。重复超治疗性摄入定义为24小时或更长时间的暴露。该指南强调获得准确历史的重要性。当摄入史确定为准确时,剂量和摄入方式用于决定治疗转诊。如果患者摄入量为:(1)24小时内≥200mg /kg或10g(以较小者为准),建议转诊至急诊科;(2) 48小时内≥150mg /kg/ 24h或6g /天(以较小者为准);(3)≥100mg /kg/ 24h或4g /天(以较小者为准),持续时间超过48h。讨论:迫切需要规范院外对扑热息痛暴露的评估和分类。尽管有可用的乙酰半胱氨酸,一些患者发展致命的肝功能衰竭由于漏诊和治疗延误。未能识别需要乙酰半胱氨酸的病例与显著的发病率和死亡率相关。结论:本共识声明为院外扑热息痛摄入管理提供循证指导,以规范扑热息痛暴露患者的医疗机构转诊标准。
{"title":"Out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure in the United States and Canada: a consensus guideline.","authors":"Evelyn J Fox, Alicia M Dalton, Michael E Mullins, Theresa Matoushek, Anne-Michelle Ruha, Michele M Burns, Karen Simone, Michael C Beuhler, Kennon J Heard, Maryann Mazer-Amirshahi, Christine M Stork, Shawn M Varney, Alexandra R Funk, F Lee Cantrell, Jon B Cole, William Banner, Andrew I Stolbach, Robert G Hendrickson, Scott N Lucyk, Marco L A Sivilotti, Mark K Su, Lewis S Nelson, Barry H Rumack, Richard C Dart","doi":"10.1080/15563650.2025.2471915","DOIUrl":"10.1080/15563650.2025.2471915","url":null,"abstract":"<p><strong>Introduction: </strong>Consensus guidelines for out-of-hospital assessment and triage of paracetamol (acetaminophen) exposure were published in 2006. Changes in the healthcare system, paracetamol ingestion trends, and availability of paracetamol-containing products necessitate an update to these guidelines. Updated guidelines were created for out-of-hospital management of paracetamol exposure in the United States and Canada.</p><p><strong>Methods: </strong>A modified Delphi consensus methodology was used to create a decision framework to evaluate clinical aspects of care related to paracetamol overdose in the out-of-hospital setting. Twenty-one panelists were selected by four clinical toxicology societies (America's Poison Centers®, American Academy of Clinical Toxicology, American College of Medical Toxicology, and Canadian Association for Poison Centres and Clinical Toxicology) to participate as panelists. Guidelines were collected from most poison centers in the United States and Canada, and systematic collection and review of medical literature was conducted.</p><p><strong>Results: </strong>The panel developed a guideline for out-of-hospital management of paracetamol exposure that encompasses acute and repeated supratherapeutic ingestion patterns. Acute ingestion is defined as any ingestion presenting within 24 h of initial ingestion, regardless of ingestion pattern. Repeated supratherapeutic ingestion is defined as an exposure that occurs over a period of 24 h or more. This guideline emphasizes the importance of obtaining accurate history. When ingestion history is determined as accurate, dosage and ingestion pattern are used to decide treatment referral. It is recommended that patients be referred to the emergency department if their ingestion amount is: (1) ≥200 mg/kg or 10 g (whichever is less) within 24 h; (2) ≥150 mg/kg/24 h or 6 g/day (whichever is less) within 48 h; (3) ≥100 mg/kg/24 h or 4 g/day (whichever is less) for more than 48 h.</p><p><strong>Discussion: </strong>The need for standardizing the out-of-hospital assessment and triage of paracetamol exposure is pressing. Despite the availability of acetylcysteine, some patients develop fatal liver failure due to missed diagnoses and delays in treatment. Failure to recognize cases requiring acetylcysteine is associated with significant morbidity and mortality.</p><p><strong>Conclusion: </strong>This consensus statement provides evidence-based guidance for out-of-hospital management of paracetamol ingestion to standardize healthcare facility referral criteria for paracetamol exposed patients.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"348-352"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143566092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe metabolic derangements in an adolescent with cannabinoid hyperemesis syndrome. 严重代谢紊乱的青少年与大麻素呕吐综合征。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-12 DOI: 10.1080/15563650.2025.2477195
John Tumberger, Tony Rianprakaisang, Amr Nabaah, Travis Langner, Francesca Pérez Marquès, Shawn Sood
{"title":"Severe metabolic derangements in an adolescent with cannabinoid hyperemesis syndrome.","authors":"John Tumberger, Tony Rianprakaisang, Amr Nabaah, Travis Langner, Francesca Pérez Marquès, Shawn Sood","doi":"10.1080/15563650.2025.2477195","DOIUrl":"10.1080/15563650.2025.2477195","url":null,"abstract":"","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"363-364"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143604224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction. 修正。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-04-01 DOI: 10.1080/15563650.2025.2486820
{"title":"Correction.","authors":"","doi":"10.1080/15563650.2025.2486820","DOIUrl":"10.1080/15563650.2025.2486820","url":null,"abstract":"","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"374"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143751310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severe hypoglycemia and hypothermia in massive metformin overdose. 大量二甲双胍过量引起严重低血糖和低体温。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-06 DOI: 10.1080/15563650.2025.2472948
Keahi M Horowitz, Alyrene Dorey, B Zane Horowitz

Introduction: Metformin is a biguanide medication thought to contribute to increased insulin sensitivity. It does not induce insulin release or act via insulin receptors, so it is not considered a common cause of hypoglycemia, even in overdose. However, massive metformin overdoses may be associated with severe hypoglycemia as well as hypothermia.

Methods: Four patients who had hypoglycemia after metformin overdoses are presented. None had access to other diabetic medications or a known diagnosis of diabetes mellitus.

Results: Severe hypoglycemia (blood glucose concentration <2.2 mmol/L [<39.6 mg/dL]) in all patients was diagnosed on presentation or within 9 h of initial presentation. Peak serum lactate concentrations were observed after hypoglycemia in each patient. Three patients developed hypothermia. Three patients received extracorporeal therapy; hemodialysis (one), continuous kidney replacement therapy (one), both modalities (one). One patient died. The remainder were discharged home within 2-6 days of presentation.

Discussion: The complex mechanisms of metformin may explain the observed progression of manifestations following large metformin overdoses.

Conclusion: Large metformin ingestions exceeding 60 g can be associated with critically low serum glucose concentrations concurrently with or preceding increases in serum lactate concentrations. Hypothermia may also occur. Further study is needed to determine the exact mechanisms and true incidence of this manifestation, which may be underrecognized.

简介:二甲双胍是一种双胍类药物,被认为有助于增加胰岛素敏感性。它不诱导胰岛素释放或通过胰岛素受体起作用,因此它不被认为是低血糖的常见原因,即使在过量服用时也是如此。然而,大量二甲双胍过量可能与严重的低血糖和低体温有关。方法:对4例二甲双胍过量用药后出现低血糖的患者进行分析。没有人能够获得其他糖尿病药物或已知的糖尿病诊断。结果:严重低血糖(血糖浓度)讨论:二甲双胍的复杂作用机制可能解释了二甲双胍大量过量后观察到的症状进展。结论:大量二甲双胍摄入超过60g可能与严重低血糖浓度同时或之前的血清乳酸浓度升高有关。体温过低也可能发生。需要进一步的研究来确定这种表现的确切机制和真实发生率,这可能被低估了。
{"title":"Severe hypoglycemia and hypothermia in massive metformin overdose.","authors":"Keahi M Horowitz, Alyrene Dorey, B Zane Horowitz","doi":"10.1080/15563650.2025.2472948","DOIUrl":"10.1080/15563650.2025.2472948","url":null,"abstract":"<p><strong>Introduction: </strong>Metformin is a biguanide medication thought to contribute to increased insulin sensitivity. It does not induce insulin release or act via insulin receptors, so it is not considered a common cause of hypoglycemia, even in overdose. However, massive metformin overdoses may be associated with severe hypoglycemia as well as hypothermia.</p><p><strong>Methods: </strong>Four patients who had hypoglycemia after metformin overdoses are presented. None had access to other diabetic medications or a known diagnosis of diabetes mellitus.</p><p><strong>Results: </strong>Severe hypoglycemia (blood glucose concentration <2.2 mmol/L [<39.6 mg/dL]) in all patients was diagnosed on presentation or within 9 h of initial presentation. Peak serum lactate concentrations were observed after hypoglycemia in each patient. Three patients developed hypothermia. Three patients received extracorporeal therapy; hemodialysis (one), continuous kidney replacement therapy (one), both modalities (one). One patient died. The remainder were discharged home within 2-6 days of presentation.</p><p><strong>Discussion: </strong>The complex mechanisms of metformin may explain the observed progression of manifestations following large metformin overdoses.</p><p><strong>Conclusion: </strong>Large metformin ingestions exceeding 60 g can be associated with critically low serum glucose concentrations concurrently with or preceding increases in serum lactate concentrations. Hypothermia may also occur. Further study is needed to determine the exact mechanisms and true incidence of this manifestation, which may be underrecognized.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"357-359"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143566018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One poison center's experience with "snake" firework ingestions. 一个解毒中心对“蛇”烟花摄入的经验。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-12 DOI: 10.1080/15563650.2025.2474563
Matthew S Correia, Adrienne Hughes, Robert G Hendrickson

Introduction: "Snake" fireworks are a type of pyrotechnic device that, when ignited, burn and transform into a friable, snake-like structure. The inclusion of barium salts produces a green flame. Ingestion of these fireworks poses a risk of barium toxicity, which may result in hypokalemia, weakness, dysrhythmias, and respiratory distress.

Methods: We evaluated firework-related cases at a single poison center between 2009 and 2023 and extracted those pertaining to snake fireworks. Cases were eligible for analysis if oral exposure was suspected or confirmed. Cases were excluded if there was no oral exposure, the missing firework was located after the initial call, or there was no longitudinal follow up after a suspected or witnessed exposure (that is, premature case closure). Pertinent details related to the exposure or those associated with barium toxicity were extracted and evaluated in a descriptive fashion.

Results: Sixty-four cases met inclusion criteria. No deaths, dysrhythmias, weakness, or respiratory compromise were reported. All six children (9.3%) who were symptomatic had gastrointestinal complaints at initial contact with our poison center. Only two symptomatic patients had hypokalemia with the minimum serum potassium concentrations falling to 3.4 mmol/L and 2.1 mmol/L. Four additional patients developed mild hypokalemia (lowest 3.0 mmol/L) but no symptoms. The maximal latency after exposure until nadir potassium concentration was 8 h.

Discussion: Oral exposures to snake fireworks occasionally resulted in mild symptomatic toxicity. The presence of symptoms did not appear to predict whether hypokalemia would develop. In the instances in which hypokalemia was present, or there was a notable downtrend in the serum potassium concentration, the repletion of potassium usually did not correlate with the extent of rebound.

Conclusion: In our case series, most children who had oral exposure to snake fireworks in an exploratory setting did not develop symptoms. Although severe toxicity reassuringly did not occur in our review, evaluation and monitoring are nevertheless prudent for symptomatic children.

简介:“蛇”烟花是一种烟火装置,当被点燃时,燃烧并变成一个易碎的蛇状结构。钡盐的加入产生绿色的火焰。摄入这些烟花有钡中毒的危险,可能导致低钾血症、虚弱、心律失常和呼吸窘迫。方法:对2009年至2023年间某中毒中心与烟花有关的病例进行评估,并提取与蛇烟花有关的病例。如果怀疑或确认有口腔接触,则有资格进行分析。如果没有口腔接触,在最初呼叫后找到丢失的烟花,或者在疑似或目击接触后没有纵向随访(即过早关闭病例),则排除病例。与暴露或与钡毒性有关的相关细节被提取出来,并以描述性的方式进行评估。结果:64例符合纳入标准。无死亡、心律失常、虚弱或呼吸损害报告。所有6名有症状的儿童(9.3%)在与中毒中心初次接触时都有胃肠道不适。仅有2例患者出现低钾血症,最低血钾浓度分别为3.4 mmol/L和2.1 mmol/L。另外4例患者出现轻度低钾血症(最低3.0 mmol/L),但无症状。接触到最低钾浓度后的最大潜伏期为8小时。讨论:口服接触蛇烟火偶尔会导致轻微的症状性毒性。症状的出现并不能预测是否会发展为低钾血症。在存在低钾血症或血清钾浓度有明显下降趋势的情况下,钾的补充通常与反弹的程度无关。结论:在我们的病例系列中,大多数在探索环境中口腔接触蛇烟火的儿童没有出现症状。虽然在我们的审查中没有出现严重的毒性,但对有症状的儿童的评估和监测仍然是谨慎的。
{"title":"One poison center's experience with \"snake\" firework ingestions.","authors":"Matthew S Correia, Adrienne Hughes, Robert G Hendrickson","doi":"10.1080/15563650.2025.2474563","DOIUrl":"10.1080/15563650.2025.2474563","url":null,"abstract":"<p><strong>Introduction: </strong>\"Snake\" fireworks are a type of pyrotechnic device that, when ignited, burn and transform into a friable, snake-like structure. The inclusion of barium salts produces a green flame. Ingestion of these fireworks poses a risk of barium toxicity, which may result in hypokalemia, weakness, dysrhythmias, and respiratory distress.</p><p><strong>Methods: </strong>We evaluated firework-related cases at a single poison center between 2009 and 2023 and extracted those pertaining to snake fireworks. Cases were eligible for analysis if oral exposure was suspected or confirmed. Cases were excluded if there was no oral exposure, the missing firework was located after the initial call, or there was no longitudinal follow up after a suspected or witnessed exposure (that is, premature case closure). Pertinent details related to the exposure or those associated with barium toxicity were extracted and evaluated in a descriptive fashion.</p><p><strong>Results: </strong>Sixty-four cases met inclusion criteria. No deaths, dysrhythmias, weakness, or respiratory compromise were reported. All six children (9.3%) who were symptomatic had gastrointestinal complaints at initial contact with our poison center. Only two symptomatic patients had hypokalemia with the minimum serum potassium concentrations falling to 3.4 mmol/L and 2.1 mmol/L. Four additional patients developed mild hypokalemia (lowest 3.0 mmol/L) but no symptoms. The maximal latency after exposure until nadir potassium concentration was 8 h.</p><p><strong>Discussion: </strong>Oral exposures to snake fireworks occasionally resulted in mild symptomatic toxicity. The presence of symptoms did not appear to predict whether hypokalemia would develop. In the instances in which hypokalemia was present, or there was a notable downtrend in the serum potassium concentration, the repletion of potassium usually did not correlate with the extent of rebound.</p><p><strong>Conclusion: </strong>In our case series, most children who had oral exposure to snake fireworks in an exploratory setting did not develop symptoms. Although severe toxicity reassuringly did not occur in our review, evaluation and monitoring are nevertheless prudent for symptomatic children.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"353-356"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143604222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical effects of acute lamotrigine overdose (ATOM-10). 急性拉莫三嗪过量(ATOM-10)的临床疗效。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-24 DOI: 10.1080/15563650.2025.2471906
Angela L Chiew, Geoffrey K Isbister, Kiet Nguyen, Kristy McCulloch, Úna Nic Ionmhain, Katherine Z Isoardi

Introduction: Lamotrigine overdose is not typically associated with severe toxicity. However, both severe toxicity and serotonin toxicity is occasionally reported following large ingestions. We aimed to investigate the clinical effects of lamotrigine overdose.

Methods: This was a prospective observational study from July 2020-March 2024. Patients >14 years-old with acute lamotrigine overdose (≥2 g ingestion) were recruited from the Australian Toxicology Monitoring study or identified from three toxicology units. Data extracted included clinical features, lamotrigine concentrations, management, and outcomes.

Results: Fifty-four patients were included, median age 29 years (IQR: 21-42 years), 37 (69%) were female. The median ingested dose was 4.8 g (IQR: 3.2-6.3 g) and 41 patients (76%) co-ingested other substances. The median maximum lamotrigine concentration was 18.5 mg/L (IQR: 12.4-25.0 mg/L) at a median time of 4.3 h (IQR: 3.2-10.8 h) post-ingestion. Clinical effects and their management included sedation in 44 (81%) with 29 patients (54%) endotracheally intubated, tachycardia in 39 (72%), hypotension in 21 (39%) with 15 (28%) receiving inotropes, and seizures in 11 (20%). Serotonin toxicity occurred in 23 (43%) patients with four having severe toxicity characterised by temperature >38.5 °C and/or rigidity treated with muscle paralysis. Higher peak lamotrigine concentrations were correlated with severe outcomes such as endotracheal intubation for coma (P <0.0001), patients with hypotension receiving inotropes (P = 0.0269) and patients developing seizures (P = 0.0002). Patients who co-ingested another serotonin agent (some in therapeutic doses) had a higher incidence of developing serotonin toxicity (22/33 [67%]) versus those who had not (1/21 [5%]); P <0.0001).

Discussion: Severe toxicity was associated with higher peak lamotrigine concentrations. Serotonin toxicity was common in those who were exposed to another serotonergic agent.

Conclusion: Coma, seizures and hypotension following lamotrigine overdose appeared to be concentration dependent. Serotonin toxicity occurred in those who co-ingested another serotonergic agent and was unrelated to lamotrigine concentration.

拉莫三嗪过量通常不伴有严重的毒性。然而,严重的毒性和血清素毒性偶尔会在大量摄入后报道。我们的目的是探讨拉莫三嗪过量的临床效果。方法:这是一项前瞻性观察研究,时间为2020年7月至2024年3月。14岁急性拉莫三嗪过量(≥2g摄入)患者从澳大利亚毒理学监测研究中招募或从三个毒理学单位中确定。提取的数据包括临床特征、拉莫三嗪浓度、管理和结果。结果:纳入患者54例,中位年龄29岁(IQR: 21 ~ 42岁),女性37例(69%)。中位摄入剂量为4.8 g (IQR: 3.2-6.3 g), 41例(76%)患者共摄入其他物质。中位最大拉莫三嗪浓度为18.5 mg/L (IQR: 12.4 ~ 25.0 mg/L),中位时间为4.3 h (IQR: 3.2 ~ 10.8 h)。临床效果及处理包括镇静44例(81%),经气管插管29例(54%),心动过速39例(72%),低血压21例(39%),使用肌力药物15例(28%),癫痫发作11例(20%)。23例(43%)患者出现血清素毒性,其中4例出现严重毒性,表现为体温低于38.5°C和/或僵硬,并伴有肌肉麻痹。较高的拉莫三嗪峰值浓度与严重后果相关,如昏迷患者气管插管(P = 0.0269)和癫痫发作(P = 0.0002)。同时摄入另一种5 -羟色胺药物的患者(有些是治疗剂量)发生5 -羟色胺毒性的发生率(22/33[67%])高于未服用的患者(1/21 [5%]);P讨论:严重的毒性与较高的拉莫三嗪峰浓度相关。血清素毒性在暴露于另一种血清素能剂的人群中很常见。结论:拉莫三嗪过量后出现昏迷、癫痫发作和低血压的浓度依赖性。血清素毒性发生在同时摄入另一种血清素能剂的患者中,与拉莫三嗪浓度无关。
{"title":"Clinical effects of acute lamotrigine overdose (ATOM-10).","authors":"Angela L Chiew, Geoffrey K Isbister, Kiet Nguyen, Kristy McCulloch, Úna Nic Ionmhain, Katherine Z Isoardi","doi":"10.1080/15563650.2025.2471906","DOIUrl":"10.1080/15563650.2025.2471906","url":null,"abstract":"<p><strong>Introduction: </strong>Lamotrigine overdose is not typically associated with severe toxicity. However, both severe toxicity and serotonin toxicity is occasionally reported following large ingestions. We aimed to investigate the clinical effects of lamotrigine overdose.</p><p><strong>Methods: </strong>This was a prospective observational study from July 2020-March 2024. Patients >14 years-old with acute lamotrigine overdose (≥2 g ingestion) were recruited from the Australian Toxicology Monitoring study or identified from three toxicology units. Data extracted included clinical features, lamotrigine concentrations, management, and outcomes.</p><p><strong>Results: </strong>Fifty-four patients were included, median age 29 years (IQR: 21-42 years), 37 (69%) were female. The median ingested dose was 4.8 g (IQR: 3.2-6.3 g) and 41 patients (76%) co-ingested other substances. The median maximum lamotrigine concentration was 18.5 mg/L (IQR: 12.4-25.0 mg/L) at a median time of 4.3 h (IQR: 3.2-10.8 h) post-ingestion. Clinical effects and their management included sedation in 44 (81%) with 29 patients (54%) endotracheally intubated, tachycardia in 39 (72%), hypotension in 21 (39%) with 15 (28%) receiving inotropes, and seizures in 11 (20%). Serotonin toxicity occurred in 23 (43%) patients with four having severe toxicity characterised by temperature >38.5 °C and/or rigidity treated with muscle paralysis. Higher peak lamotrigine concentrations were correlated with severe outcomes such as endotracheal intubation for coma (<i>P</i> <0.0001), patients with hypotension receiving inotropes (<i>P</i> = 0.0269) and patients developing seizures (<i>P</i> = 0.0002). Patients who co-ingested another serotonin agent (some in therapeutic doses) had a higher incidence of developing serotonin toxicity (22/33 [67%]) versus those who had not (1/21 [5%]); <i>P</i> <0.0001).</p><p><strong>Discussion: </strong>Severe toxicity was associated with higher peak lamotrigine concentrations. Serotonin toxicity was common in those who were exposed to another serotonergic agent.</p><p><strong>Conclusion: </strong>Coma, seizures and hypotension following lamotrigine overdose appeared to be concentration dependent. Serotonin toxicity occurred in those who co-ingested another serotonergic agent and was unrelated to lamotrigine concentration.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"310-316"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143691215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative evaluation of the ability to detect major cardiac events with the modified cocaine history, electrocardiogram, age, risk factors and troponin (HEART) score, HEART pathway and original HEART score in patients with cocaine-associated chest pain presenting at the emergency department. 在急诊科就诊的可卡因相关胸痛患者中,修改可卡因病史、心电图、年龄、危险因素、肌钙蛋白(HEART)评分、HEART通路和原始HEART评分对主要心脏事件检测能力的比较评价
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-04-14 DOI: 10.1080/15563650.2025.2472955
Femke Gresnigt, Jelle van Essen, Claudine Hunault, Eric Franssen, Dylan de Lange, Robert Riezebos

Introduction: This study primarily aimed to assess the ability to detect major cardiac events using the history, electrocardiogram, age, risk factors and troponin (HEART) pathway, modified cocaine HEART score, and HEART score among patients with cocaine-associated chest pain.

Methods: This single-centre retrospective study included consecutive patients with cocaine-associated chest pain admitted between January 2016 and December 2022 who were age and sex-matched in a 1:2 ratio to patients with chest pain not associated with cocaine use. The primary outcome was the percentage of major adverse cardiovascular events within 30 days.

Results: In total, 1,412 patients were included, with 1,653 presentations, of whom 551 presented with cocaine-associated chest pain and were ≥18 years old. Most presentations involved male patients (84%). Major adverse cardiovascular events occurred in 139 presentations: 50 (9.1%) among patients with cocaine-associated chest pain and 89 (8.1%) among patients with non-cocaine-associated chest pain. The number of low-risk presentations of cocaine-associated chest pain patients was 409 (74.2%), 345 (62.6%) and 394 (71.5%) according to the HEART score, modified cocaine HEART score and HEART pathway, respectively. The HEART pathway had the lowest percentage of observed major adverse cardiac events in low-risk patients (0%; 95% CI: 0-0.9%), followed by the modified cocaine HEART score (0.3%; 95% CI: 0.007-1.6%) and the HEART score (0.7%; 95% CI: 0.2-2.1%). Sensitivity, negative predictive value, and area under the curves were very similar between the three scores.

Discussion: The occurrence of missed major adverse cardiovascular events in low-risk patients was below 0.7% (95% CI: 0.2%-2.1%) in all three risk stratification scores. The HEART pathway was the safest risk stratification tool with a sensitivity and negative predictive value of 100%. Nevertheless the differences with the other risk stratification scores were non-significant.

Conclusions: All three risk stratification scores performed well in a low-risk population with cocaine-associated chest pain, with a percentage of 0.7% of patients with a missed major adverse cardiovascular event.

简介:本研究主要目的是评估使用病史、心电图、年龄、危险因素和肌钙蛋白(HEART)途径、改良可卡因心脏评分和可卡因相关胸痛患者的心脏评分来检测主要心脏事件的能力。方法:这项单中心回顾性研究纳入了2016年1月至2022年12月期间入院的连续可卡因相关胸痛患者,这些患者的年龄和性别与非可卡因相关胸痛患者的比例为1:2。主要终点是30天内主要不良心血管事件的百分比。结果:共纳入1412例患者,1653例表现,其中551例表现为可卡因相关胸痛,年龄≥18岁。大多数患者为男性(84%)。139例患者出现主要不良心血管事件:50例(9.1%)为可卡因相关胸痛患者,89例(8.1%)为非可卡因相关胸痛患者。根据HEART评分、改良可卡因HEART评分和HEART途径,可卡因相关胸痛患者的低危表现分别为409例(74.2%)、345例(62.6%)和394例(71.5%)。在低危患者中,HEART通路观察到的主要心脏不良事件百分比最低(0%;95% CI: 0-0.9%),其次是改良可卡因心脏评分(0.3%;95% CI: 0.007-1.6%)和HEART评分(0.7%;95% ci: 0.2-2.1%)。灵敏度、负预测值和曲线下面积在三个得分之间非常相似。讨论:在所有三个风险分层评分中,低危患者的主要不良心血管事件漏报率低于0.7% (95% CI: 0.2%-2.1%)。HEART途径是最安全的风险分层工具,敏感性和阴性预测值为100%。然而,与其他风险分层评分的差异不显著。结论:在低风险人群中,所有三种风险分层评分在可卡因相关胸痛患者中表现良好,遗漏主要不良心血管事件的患者比例为0.7%。
{"title":"Comparative evaluation of the ability to detect major cardiac events with the modified cocaine history, electrocardiogram, age, risk factors and troponin (HEART) score, HEART pathway and original HEART score in patients with cocaine-associated chest pain presenting at the emergency department.","authors":"Femke Gresnigt, Jelle van Essen, Claudine Hunault, Eric Franssen, Dylan de Lange, Robert Riezebos","doi":"10.1080/15563650.2025.2472955","DOIUrl":"10.1080/15563650.2025.2472955","url":null,"abstract":"<p><strong>Introduction: </strong>This study primarily aimed to assess the ability to detect major cardiac events using the history, electrocardiogram, age, risk factors and troponin <b>(</b>HEART) pathway, modified cocaine HEART score, and HEART score among patients with cocaine-associated chest pain.</p><p><strong>Methods: </strong>This single-centre retrospective study included consecutive patients with cocaine-associated chest pain admitted between January 2016 and December 2022 who were age and sex-matched in a 1:2 ratio to patients with chest pain not associated with cocaine use. The primary outcome was the percentage of major adverse cardiovascular events within 30 days.</p><p><strong>Results: </strong>In total, 1,412 patients were included, with 1,653 presentations, of whom 551 presented with cocaine-associated chest pain and were ≥18 years old. Most presentations involved male patients (84%). Major adverse cardiovascular events occurred in 139 presentations: 50 (9.1%) among patients with cocaine-associated chest pain and 89 (8.1%) among patients with non-cocaine-associated chest pain. The number of low-risk presentations of cocaine-associated chest pain patients was 409 (74.2%), 345 (62.6%) and 394 (71.5%) according to the HEART score, modified cocaine HEART score and HEART pathway, respectively. The HEART pathway had the lowest percentage of observed major adverse cardiac events in low-risk patients (0%; 95% CI: 0-0.9%), followed by the modified cocaine HEART score (0.3%; 95% CI: 0.007-1.6%) and the HEART score (0.7%; 95% CI: 0.2-2.1%). Sensitivity, negative predictive value, and area under the curves were very similar between the three scores.</p><p><strong>Discussion: </strong>The occurrence of missed major adverse cardiovascular events in low-risk patients was below 0.7% (95% CI: 0.2%-2.1%) in all three risk stratification scores. The HEART pathway was the safest risk stratification tool with a sensitivity and negative predictive value of 100%. Nevertheless the differences with the other risk stratification scores were non-significant.</p><p><strong>Conclusions: </strong>All three risk stratification scores performed well in a low-risk population with cocaine-associated chest pain, with a percentage of 0.7% of patients with a missed major adverse cardiovascular event.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"317-324"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143991677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subclinical adrenal suppression and urine immunoassay detection of etomidate in an electronic cigarette user. 电子烟使用者亚临床肾上腺抑制和尿免疫分析检测依托咪酯。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-17 DOI: 10.1080/15563650.2025.2476016
Stephanie Tak Hei Liang, Rex Pui Kin Lam, Ngo Tin James Chan, Martin Mou Know Leung, Sik Hon Tsui, Timothy Hudson Rainer
{"title":"Subclinical adrenal suppression and urine immunoassay detection of etomidate in an electronic cigarette user.","authors":"Stephanie Tak Hei Liang, Rex Pui Kin Lam, Ngo Tin James Chan, Martin Mou Know Leung, Sik Hon Tsui, Timothy Hudson Rainer","doi":"10.1080/15563650.2025.2476016","DOIUrl":"10.1080/15563650.2025.2476016","url":null,"abstract":"","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"364-366"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143647575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to the performance of timely hemodialysis when recommended by one United States poison center: a retrospective review. 美国某毒物中心推荐及时进行血液透析的障碍:回顾性回顾。
IF 3 3区 医学 Q2 TOXICOLOGY Pub Date : 2025-04-01 Epub Date: 2025-02-10 DOI: 10.1080/15563650.2025.2454292
Marlis Gnirke, Emily Davies, Robert S Hoffman, Mark K Su

Introduction: Hemodialysis has an essential role in the treatment of certain poisoned patients, both by enhancing the elimination of select poisons and correcting underlying fluid, electrolyte, and acid-base disturbances. We sought to identify barriers to the performance of hemodialysis when it was recommended by our poison center.

Methods: Data from a single United States poison center were retrospectively queried for adult patients for whom the poison center recommended intermittent hemodialysis for poison removal. The primary outcome was the performance of intermittent hemodialysis within 12 h of the poison center recommendation, which we defined as timely hemodialysis. Univariable and multivariable logistic regressions were performed to assess the effect of the following variables on this outcome: age group, patient sex, time of day of the recommendation, day of week of the recommendation, year of the recommendation, hospital location, and poison category.

Results: A total of 535 patient encounters were analyzed. The majority (73.5%) of patients had intermittent hemodialysis performed within 12 h of when it was recommended. The multivariable analyses showed that the odds of receiving recommended intermittent hemodialysis within 12 h were significantly lower when the recommendation was made during the nighttime (OR: 0.660; 95% CI: 0.442-0.987) compared to daytime and during the weekend (OR: 0.605; 95% CI: 0.398-0.918) compared to weekdays.

Discussion: Intermittent hemodialysis is resource-intensive and requires specialized equipment and personnel, which is likely less available outside of regular business hours. This study is limited by its retrospective nature and may not be generalizable to other poison centers.

Conclusion: Patients for whom our poison center recommended intermittent hemodialysis during non-weekday times had lower odds of receiving timely hemodialysis. Hospital administrators and healthcare providers should be aware of this potential treatment obstacle for poisoned patients and identify the specific barriers involved in order to facilitate timely hemodialysis.

导论:血液透析在某些中毒患者的治疗中具有重要作用,既可以加强消除选定的毒物,又可以纠正潜在的液体、电解质和酸碱紊乱。当我们的中毒中心推荐血液透析时,我们试图确定血液透析的障碍。方法:回顾性查询美国某中毒中心推荐间歇性血液透析脱毒的成年患者的资料。主要结局是在中毒中心推荐的12小时内间歇性血液透析的表现,我们将其定义为及时血液透析。采用单变量和多变量logistic回归来评估以下变量对该结果的影响:年龄组、患者性别、推荐的时间、推荐的星期几、推荐的年份、医院位置和中毒类别。结果:共分析535例患者就诊情况。大多数(72%)患者在推荐后12小时内进行了间歇性血液透析。多变量分析显示,当夜间推荐时,在12小时内接受推荐的间歇性血液透析的几率显著降低(OR: 0.660;95% CI: 0.442-0.987),与白天和周末(OR: 0.605;95% CI: 0.398-0.918)。讨论:间歇血液透析是资源密集型的,需要专门的设备和人员,在正常营业时间之外可能较少。本研究受限于其回顾性性质,可能无法推广到其他毒物中心。结论:毒理中心推荐非工作日间歇血液透析的患者及时接受血液透析的几率较低。医院管理人员和医疗保健提供者应该意识到中毒患者的潜在治疗障碍,并确定所涉及的具体障碍,以便及时进行血液透析。
{"title":"Barriers to the performance of timely hemodialysis when recommended by one United States poison center: a retrospective review.","authors":"Marlis Gnirke, Emily Davies, Robert S Hoffman, Mark K Su","doi":"10.1080/15563650.2025.2454292","DOIUrl":"10.1080/15563650.2025.2454292","url":null,"abstract":"<p><strong>Introduction: </strong>Hemodialysis has an essential role in the treatment of certain poisoned patients, both by enhancing the elimination of select poisons and correcting underlying fluid, electrolyte, and acid-base disturbances. We sought to identify barriers to the performance of hemodialysis when it was recommended by our poison center.</p><p><strong>Methods: </strong>Data from a single United States poison center were retrospectively queried for adult patients for whom the poison center recommended intermittent hemodialysis for poison removal. The primary outcome was the performance of intermittent hemodialysis within 12 h of the poison center recommendation, which we defined as timely hemodialysis. Univariable and multivariable logistic regressions were performed to assess the effect of the following variables on this outcome: age group, patient sex, time of day of the recommendation, day of week of the recommendation, year of the recommendation, hospital location, and poison category.</p><p><strong>Results: </strong>A total of 535 patient encounters were analyzed. The majority (73.5%) of patients had intermittent hemodialysis performed within 12 h of when it was recommended. The multivariable analyses showed that the odds of receiving recommended intermittent hemodialysis within 12 h were significantly lower when the recommendation was made during the nighttime (OR: 0.660; 95% CI: 0.442-0.987) compared to daytime and during the weekend (OR: 0.605; 95% CI: 0.398-0.918) compared to weekdays.</p><p><strong>Discussion: </strong>Intermittent hemodialysis is resource-intensive and requires specialized equipment and personnel, which is likely less available outside of regular business hours. This study is limited by its retrospective nature and may not be generalizable to other poison centers.</p><p><strong>Conclusion: </strong>Patients for whom our poison center recommended intermittent hemodialysis during non-weekday times had lower odds of receiving timely hemodialysis. Hospital administrators and healthcare providers should be aware of this potential treatment obstacle for poisoned patients and identify the specific barriers involved in order to facilitate timely hemodialysis.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"267-272"},"PeriodicalIF":3.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143381777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Toxicology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1